ZA201202495B - Combination - Google Patents

Combination

Info

Publication number
ZA201202495B
ZA201202495B ZA2012/02495A ZA201202495A ZA201202495B ZA 201202495 B ZA201202495 B ZA 201202495B ZA 2012/02495 A ZA2012/02495 A ZA 2012/02495A ZA 201202495 A ZA201202495 A ZA 201202495A ZA 201202495 B ZA201202495 B ZA 201202495B
Authority
ZA
South Africa
Prior art keywords
combination
Prior art date
Application number
ZA2012/02495A
Other languages
English (en)
Inventor
Melissa Dumble
Tona Gilmer
Rakesh Kumar
Sylvie Laquerre
Peter F Lebowitz
Shannon Renae Morris
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of ZA201202495B publication Critical patent/ZA201202495B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA2012/02495A 2009-10-08 2012-04-05 Combination ZA201202495B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24980809P 2009-10-08 2009-10-08
PCT/US2010/051909 WO2011044415A1 (en) 2009-10-08 2010-10-08 Combination

Publications (1)

Publication Number Publication Date
ZA201202495B true ZA201202495B (en) 2013-01-30

Family

ID=43857163

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/02495A ZA201202495B (en) 2009-10-08 2012-04-05 Combination

Country Status (14)

Country Link
US (1) US8796298B2 (enExample)
EP (1) EP2485594B1 (enExample)
JP (1) JP5881607B2 (enExample)
KR (1) KR101696003B1 (enExample)
CN (1) CN102647908B (enExample)
AU (1) AU2010303364B2 (enExample)
BR (1) BR112012008274A2 (enExample)
CA (1) CA2777087C (enExample)
EA (1) EA023018B1 (enExample)
ES (1) ES2530436T3 (enExample)
IL (1) IL219000A (enExample)
MX (1) MX2012004140A (enExample)
WO (1) WO2011044415A1 (enExample)
ZA (1) ZA201202495B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201600077RA (en) 2011-01-11 2016-02-26 Glaxosmithkline Llc Combination
CN104540822B (zh) * 2013-07-08 2016-08-31 杭州普晒医药科技有限公司 达拉菲尼甲磺酸盐的晶型及其制备方法
CN107949642B (zh) * 2015-05-27 2022-04-26 奎斯特诊断投资股份有限公司 用于筛选实体瘤的组合物和方法
WO2020055760A1 (en) * 2018-09-10 2020-03-19 Mirati Therapeutics, Inc. Combination therapies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE309205T1 (de) * 1999-01-13 2005-11-15 Warner Lambert Co Benzenesulfonamid-derivative und ihre verwendung als mek-inhibitoren
WO2004080972A1 (en) * 2003-03-12 2004-09-23 Vertex Pharmaceuticals Incorporated Pirazole modulators of atp-binding cassette transporters
BRPI0706621A2 (pt) * 2006-01-18 2011-04-05 Amgen Inc composto, composição farmacêutica, métodos para tratar um distúrbio mediado por quinase em um mamìfero e para tratar um distúrbio relacionado com a proliferação em um mamìfero, e , uso do composto
UY30892A1 (es) * 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
UA103319C2 (en) * 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds

Also Published As

Publication number Publication date
EP2485594B1 (en) 2015-01-07
MX2012004140A (es) 2012-09-07
IL219000A0 (en) 2012-06-28
AU2010303364B2 (en) 2013-09-19
JP5881607B2 (ja) 2016-03-09
CN102647908B (zh) 2014-02-19
EP2485594A4 (en) 2013-02-13
BR112012008274A2 (pt) 2015-09-22
CA2777087C (en) 2017-10-31
EA023018B1 (ru) 2016-04-29
ES2530436T3 (es) 2015-03-02
EP2485594A1 (en) 2012-08-15
EA201270527A1 (ru) 2012-12-28
US8796298B2 (en) 2014-08-05
WO2011044415A1 (en) 2011-04-14
IL219000A (en) 2015-02-26
KR101696003B1 (ko) 2017-01-13
AU2010303364A1 (en) 2012-04-26
CA2777087A1 (en) 2011-04-14
CN102647908A (zh) 2012-08-22
US20120202835A1 (en) 2012-08-09
JP2013507383A (ja) 2013-03-04
KR20120093931A (ko) 2012-08-23

Similar Documents

Publication Publication Date Title
ZA201202612B (en) Combination
DK2442650T4 (en) Sublingualt apomorfin
EP2462514A4 (en) GREEN BOOKS
IL219103A0 (en) Combination
IL219786A0 (en) Combination
ZA201202494B (en) Combination
ZA201202173B (en) Combination
ZA201202495B (en) Combination
ZA201202258B (en) Combination
GB0902556D0 (en) Gjk121
IL218801A0 (en) Combination
AU4240P (en) Tuckerbox xTriticosecale
GB0901391D0 (en) Combination
GB0906696D0 (en) Combination
GB0921334D0 (en) Preferred combination
GB0905116D0 (en) IssueControl
AP2009000324S (en) Rudpak
GB0901386D0 (en) VacuRag
GB0900671D0 (en) Tugbug
GB0900651D0 (en) Birdcatcher
GB0900183D0 (en) Lugg-Scan
GB0902438D0 (en) Corcost-t10
GB0903794D0 (en) Scopesights
GB0901754D0 (en) Vac-brush
GB0901630D0 (en) BridgeEye